Search Results

Biotech Beach

Trailblazing work with 3D Human Liver Models Yields Accurate MASH (formerly NASH) Phenotype

Viscient Biosciences announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk Institute, have published the first demonstration of a liver fibrosis phenotype in a 3D human tissue model of MASH demonstrating strong comparability to the native disease by multiple measures.

January 23, 2024

·

5 min read

Pharm Country

Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics

Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.

May 17, 2024

·

3 min read

Immutep successfully completes institutional placement and institutional component of entitlement offer

Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.

June 5, 2024

·

7 min read

Press Releases

Quantum Computing, Inc. Announces Collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute To Support Research Using Dirac-3 Systems

January 15, 2025

·

4 min read

Press Releases

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development

February 6, 2025

·

12 min read

Press Releases

Rigel’s Fostamatinib Being Studied by National Institute of Health in Patients with Sickle Cell Disease

January 23, 2025

·

10 min read

Press Releases

Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference

February 18, 2025

·

1 min read

Press Releases

Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection

January 7, 2025

·

4 min read

Press Releases

ICU Medical to Present at the Raymond James 46th Annual Institutional Investors Conference

February 14, 2025

·

1 min read

Business

Salk Institute and BridgeBio Pharma Collaborate to Advance Therapies for Genetically Driven Disease

The Salk Institute and BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced a three-year collaboration agreement formed to advance cutting-edge academic discoveries in genetically driven diseases toward therapeutic applications.

October 21, 2020

·

5 min read